Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach.

PubWeight™: 1.67‹?› | Rank: Top 3%

🔗 View Article (PMID 19091337)

Published in J Urol on December 16, 2008

Authors

Katie N Ballert1, Grace Y Biggs, Anthony Isenalumhe, Nirit Rosenblum, Victor W Nitti

Author Affiliations

1: Department of Urology, New York University, New York, New York 10016, USA.

Articles citing this

When are urodynamics indicated in patients with stress urinary incontinence? Curr Urol Rep (2012) 1.39

Incidence and risk factors of postoperative stress urinary incontinence following laparoscopic sacrocolpopexy in patients with negative preoperative prolapse reduction stress testing. Int Urogynecol J (2012) 0.86

Occult incontinence as predictor for postoperative stress urinary incontinence following pelvic organ prolapse surgery. Int Urogynecol J (2012) 0.83

Outcomes of two different incision techniques for surgical treatment of stress urinary incontinence with concomitant anterior vaginal wall prolapse. World J Urol (2014) 0.78

Does concomitant vaginal prolapse repair affect the outcomes of the transobturator tape procedure in the long term? Int Urogynecol J (2014) 0.76

Voiding difficulties after vaginal mesh cystocele repair: does the perivesical dissection matter? Int Urogynecol J (2013) 0.75

Urodynamics, Incontinence, and Neurourology: Highlights from the Society for Urodynamics and Female Urology Annual Winter Meeting, February 28-March 2, 2008, Miami, FL. Rev Urol (2008) 0.75

Urinary incontinence: treating occult SUI-are two steps better than one? Nat Rev Urol (2012) 0.75

Advances in managing pelvic floor disorders. F1000 Med Rep (2009) 0.75

Stress incontinence surgery at the time of prolapse surgery: mandatory or forbidden? World J Urol (2015) 0.75

Changes in urodynamic measurements and bladder neck position after single-incision trans-vaginal mesh for pelvic organ prolapse. Int Urogynecol J (2015) 0.75

Articles by these authors

Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol (2010) 2.68

Artificial urinary sphincter revision: the role of ultrasound. Urology (2013) 2.62

Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01

An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73

Ten-year experience with transvaginal vesicovaginal fistula repair using tissue interposition. J Urol (2003) 1.72

Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51

Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49

Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol (2009) 1.30

American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology (2003) 1.30

Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn (2013) 1.17

Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol (2006) 1.14

Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2008) 1.11

Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int (2010) 1.10

Female urethral reconstruction. Urol Clin North Am (2011) 1.01

Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes? Curr Opin Urol (2006) 0.99

MRI of pelvic floor dysfunction: dynamic true fast imaging with steady-state precession versus HASTE. AJR Am J Roentgenol (2008) 0.96

The male perineal sling: assessment and prediction of outcome. J Urol (2007) 0.95

Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J (2011) 0.95

Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.94

Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling. Neurourol Urodyn (2007) 0.94

A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn (2005) 0.90

Primary bladder neck obstruction in men and women. Rev Urol (2005) 0.90

Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90

Patient-reported outcomes for tension-free vaginal tape-obturator in women treated with a previous anti-incontinence procedure. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.88

Perineocele: symptom complex, description of anatomic defect, and surgical technique for repair. Urology (2006) 0.88

Urinary incontinence. Prim Care (2010) 0.88

Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology (2002) 0.87

Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J (2014) 0.87

Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol (2011) 0.87

Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status. J Am Coll Surg (2009) 0.87

Patient perception of videourodynamic testing: a questionnaire based study. J Urol (2005) 0.86

Clinical impact of overactive bladder. Rev Urol (2002) 0.85

Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am (2012) 0.85

Management of recurrent urinary tract infections in healthy adult women. Rev Urol (2013) 0.84

Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol (2003) 0.84

Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol (2009) 0.84

Degree of bother caused by nocturia in women. Neurourol Urodyn (2004) 0.83

Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology (2003) 0.83

Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol (2010) 0.81

Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.81

Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int (2005) 0.81

Recent advances in management of female lower urinary tract trauma. Curr Opin Urol (2003) 0.80

Primary bladder neck obstruction in men, women, and children. Curr Urol Rep (2007) 0.80

Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology (2012) 0.80

Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol (2004) 0.79

Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.78

Long-term continence after surgery--what can we tell patients? J Urol (2012) 0.78

Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology (2008) 0.78

Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep (2005) 0.77

Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg (2013) 0.77

Can noninvasive evaluation of benign prostatic obstruction be optimized? Curr Opin Urol (2012) 0.77

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol (2014) 0.77

Repair of pelvic organ prolapse: what is the goal? Curr Urol Rep (2014) 0.77

Tolterodine for treatment of overactive bladder. Urol Clin North Am (2006) 0.76

Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn (2005) 0.76

Endoscopic evacuation of Durasphere. Urology (2003) 0.76

Editorial comment. Urology (2011) 0.75

Transdermal therapy for overactive bladder: present and future. Rev Urol (2003) 0.75

Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol (2005) 0.75

Editorial comment. Urology (2011) 0.75

Reply: To PMID 24295256. Urology (2013) 0.75

Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol (2013) 0.75

Urodynamic findings in women with insensible incontinence. Int J Urol (2012) 0.75

Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am (2004) 0.75

Uterine sparing robotic-assisted laparoscopic sacrohysteropexy for pelvic organ prolapse: safety and feasibility. J Endourol (2013) 0.75

Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol (2003) 0.75

Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.75

Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol (2009) 0.75

MRI of the urethra in women with lower urinary tract symptoms: spectrum of findings at static and dynamic imaging. AJR Am J Roentgenol (2009) 0.75

Management of urinary retention and obstruction following surgery for stress urinary incontinence. Curr Urol Rep (2002) 0.75